Rankings
▼
Calendar
BDSX Q2 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$151M
Q2 2021 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$12M
+180.4% YoY
Gross Profit
$5M
40.4% margin
Operating Income
-$11M
-89.1% margin
Net Income
-$11M
-95.9% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
-58.8%
Cash Flow
Operating Cash Flow
$1M
Free Cash Flow
$742,000
Stock-Based Comp.
$539,000
Balance Sheet
Total Assets
$102M
Total Liabilities
$76M
Stockholders' Equity
$26M
Cash & Equivalents
$56M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$12M
$4M
+180.4%
Gross Profit
$5M
$2M
+103.0%
Operating Income
-$11M
-$6M
-88.4%
Net Income
-$11M
-$8M
-37.9%
Revenue Segments
Diagnostic Tests
$11M
91%
Service
$1M
9%
← FY 2021
All Quarters
Q3 2021 →